You are here

{Trans Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of 12 Prospective Cohort Studies in the Fatty Acids and Outcomes Research Consortium (FORCE)

Title{Trans Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of 12 Prospective Cohort Studies in the Fatty Acids and Outcomes Research Consortium (FORCE)
Publication TypeJournal Article
Year of Publication2022
AuthorsLai, HTM, Imamura, F, Korat, AVA, Murphy, RA, Tintle, N, Bassett, JK, Chen, J, ger, J, Chien, KL, Senn, M, Wood, AC, Forouhi, NG, Schulze, MB, Harris, WS, Vasan, RS, Hu, F, Giles, GG, Hodge, A, Djousse, L, Brouwer, IA, Qian, F, Sun, Q, Wu, JHY, Marklund, M, Lemaitre, RN, Siscovick, DS, Fretts, AM, Shadyab, AH, Manson, JE, Howard, BV, Robinson, JG, Wallace, RB, Wareham, NJ, Chen, YI, Rotter, JI, Tsai, MY, Micha, R, Mozaffarian, D
JournalDiabetes Care
Volume45
Pagination854–863
Date PublishedApr
AbstractTrans fatty acids (TFAs) have harmful biologic effects that could increase the risk of type 2 diabetes (T2D), but evidence remains uncertain. We aimed to investigate the prospective associations of TFA biomarkers and T2D by conducting an individual participant-level pooled analysis.\ 18 years without prevalent diabetes. Each cohort conducted de novo harmonized analyses using a prespecified protocol, and findings were pooled using inverse-variance weighted meta-analysis. Heterogeneity was explored by prespecified between-study and within-study characteristics.\ 0.1).\ Circulating individual trans-18:2 TFA biomarkers were not associated with risk of T2D, while trans-16:1n-9, total trans-18:1, and total trans-18:2 were inversely associated. Findings may reflect the influence of mixed TFA sources (industrial vs. natural ruminant), a general decline in TFA exposure due to policy changes during this period, or the relatively limited range of TFA levels.
ePub date: 
22/04